• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Abdelkader, N. (2021). STUDYING THE CORRELATION BETWEEN FIRST TRIMESTER SERUM FERRITIN CONCENTRATION AND DIAGNOSIS OF GESTATIONAL DIABETES. ALEXMED ePosters, 3(4), 15-16. doi: 10.21608/alexpo.2021.85640.1216
Nourhan El Sayed Abdelkader. "STUDYING THE CORRELATION BETWEEN FIRST TRIMESTER SERUM FERRITIN CONCENTRATION AND DIAGNOSIS OF GESTATIONAL DIABETES". ALEXMED ePosters, 3, 4, 2021, 15-16. doi: 10.21608/alexpo.2021.85640.1216
Abdelkader, N. (2021). 'STUDYING THE CORRELATION BETWEEN FIRST TRIMESTER SERUM FERRITIN CONCENTRATION AND DIAGNOSIS OF GESTATIONAL DIABETES', ALEXMED ePosters, 3(4), pp. 15-16. doi: 10.21608/alexpo.2021.85640.1216
Abdelkader, N. STUDYING THE CORRELATION BETWEEN FIRST TRIMESTER SERUM FERRITIN CONCENTRATION AND DIAGNOSIS OF GESTATIONAL DIABETES. ALEXMED ePosters, 2021; 3(4): 15-16. doi: 10.21608/alexpo.2021.85640.1216

STUDYING THE CORRELATION BETWEEN FIRST TRIMESTER SERUM FERRITIN CONCENTRATION AND DIAGNOSIS OF GESTATIONAL DIABETES

Article 183, Volume 3, Issue 4, December 2021, Page 15-16  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.85640.1216
View on SCiNiTO View on SCiNiTO
Author
Nourhan El Sayed Abdelkader email
Department of Gynecology and Obstetrics, Faculty of Medicine, University of Alexandria
Abstract
Gestational diabetes mellitus (GDM) according to the American diabetes association 2021, is diabetes that is first diagnosed in the second or third trimester of pregnancy that is not clearly either preexisting type 1 or type 2 diabetes. GDM is linked to an increased risk of macrosomia, neonatal hypoglycemia, preterm birth, or neonatal hyperbilirubinemia, as well as the mother having a higher risk of preeclampsia, dystocia and long‐ term complications such as type 2 diabetes mellitus.
Based on the "Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study" and the current WHO recommendations, GDM diagnosis is accomplished with.
One-step (75 gm OGTT): the diagnosis of GDM is made when any of the following plasma glucose values are met or exceeded: Fasting: 92 mg/dl, 1 h: 180 mg/dl, 2 h: 153 mg/dl. A single elevated value is sufficient for the diagnosis and already requires a strict metabolic control.
High iron stores in the liver may induce insulin resistance by impairing insulin signaling and by attenuating the liver’s ability to extract insulin. In adipocytes, excess iron can diminish insulin-induced glucose transport, whereas in the muscles it may lead to a switch from glucose to fatty acid oxidation
Keywords
GDM; FERRITIN; high risk
Supplementary Files
download 0015-1216 Presentation111 (6).pdf
Statistics
Article View: 120
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.